Results of Surgical Treatment of Lung Cancer in Patients of Different Age Groups

Abstract

Background: Lung cancer is one of the most common cancers in the world. The main objective of our study was to analyze the results of the surgical treatment of non-small cell lung cancer (NSCLC) in patients of different age groups. Methods and Results:We examined 280 patients (262/93.6% men and 18/6.4% women) aged from 39 to 75 years with NSCLC who underwent surgical treatment in the Ulyanovsk Regional Oncology Center in the period from 2010 to 2016. The mean age of patients was 64.9±10.1 years. Concomitant diseases were identified in 256(91.4%) patients: cardiovascular diseases in 170(60.7%), chronic obstructive pulmonary disease in 147(52.5%), lower extremity peripheral artery disease (stages II and III chronic ischemia) in 49(17.5%), a combination of concomitant pathology in 110(39.3%) patients. A total of 85(30.4%) pneumonectomies were performed, 56 of them in patients of young and middle age. Among early postoperative complications, the most frequent complications were purulent-inflammatory complications of the soft tissues of wounds (38.5%) and bronchopleural fistula (31.1%). The most severe complications, such as myocardial infarction, acute stroke, and acute limb ischemia, developed in patients with concomitant cardiovascular diseases, which caused the postoperative mortality of 4.6%. There were no statistically significant differences in the structure of postoperative complications depending on sex and age.

Evaluation of Surgical Treatment of Patients With Lung Cancer

“…Бронхиальные свищи -самые грозные осложнения радикального лечения рака легкого [7,10,11]. Во многих хирургических клиниках мира, специализирующихся на лечении больных раком легкого, данное осложнение после пневмонэктомий достигает 12 % [1-3], а послеоперационная летальность -50 % и выше [7-…”

“…Из-за образования бронхиального свища через культю бронха циркулирует воздух, что способствует ухудшению общего состояния больных из-за развития дыхательной недостаточности и эндотоксикоза [8,9,11].…”

Treatment of Pleural Effusion after Lobectomy and Lymphadenectomy for Primary Lung Cancer: A Case Report

“…We believe that applying the developed method prevents purulent-inflammatory complications, which often develop with prolonged drainage of the pleural cavity. (3,(7)(8)(9) The described technique is used in the Ulyanovsk Regional Oncology Clinical Dispensary and has been performed on 23 patients with a positive result.…”